The committee is being asked to make a technical correction and add language to deal with an identified problem facing professional Horseracing. The attached memo proposes amendments to ARCI-008-010 General Provisions and ARCI-022-008-010 General Provisions.
The RMTC has recommended a penalty classification for Troparil of 1/A. Troparil is not FDA approved for use in any species and the use of this drug is considered by RMTC to be an emerging threat in the U.S.
The RMTC is recommending a penalty classification for Cabergoline of 2/A. Cabergoline is not FDA approved for use in animals and is not considered a therapeutic agent for use in horses.
Proposed Amendment to ARCI-004-015 Account Wagering This year’s high-profile breaches of gaming accounts has raised the issue of safeguards taken in racing by companies offering approved account wagering opportunities in member jurisdictions.
11/10/2023 UPDATE: It was determined at the summer meeting that some member jurisdictions would reach out to the Horseracing Integrity and Safety Authority to facilitate a cooperative sharing of regulatory data so State Commissions would fulfill their responsibilities. The Committee will be updated on those contacts and how RCI staff has worked around the obstacles…
12/10/2023 – This item is on the agenda again for discussion purposes and to hear input from the field. As the issue was featured at the University of Arizona’s Global Symposium on Racing and Gaming immediately preceding the meeting, the committee members may wish to revisit the matter and this discussion will determine what, if…
